Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
      • "Best of" Collection
  • First Disclosures
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles: Therapeutics, Targets, and Development

A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance

Julia S. Samaddar, Virgil T. Gaddy, Jennifer Duplantier, Sudharsan Periyasamy Thandavan, Manish Shah, Marlena J. Smith, Darren Browning, Jim Rawson, Sylvia B. Smith, John T. Barrett and Patricia V. Schoenlein
Julia S. Samaddar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Virgil T. Gaddy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Duplantier
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sudharsan Periyasamy Thandavan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manish Shah
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marlena J. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Darren Browning
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jim Rawson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvia B. Smith
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John T. Barrett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia V. Schoenlein
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1535-7163.MCT-08-0447 Published September 2008
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: September 2008 to April 2021

AbstractFull-text HTMLPDF
Total239745292421

Cited By

Article Information

Volume 7, Issue 9, pp. 2977-2987

DOI 
https://doi.org/10.1158/1535-7163.MCT-08-0447
PubMed 
18790778

Published By 
American Association for Cancer Research
Print ISSN 
1535-7163
Online ISSN 
1538-8514
History 
  • June 7, 2008
  • July 27, 2007
  • May 7, 2008
  • Published first September 11, 2008.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Julia S. Samaddar1,
  2. Virgil T. Gaddy1,
  3. Jennifer Duplantier1,
  4. Sudharsan Periyasamy Thandavan1,
  5. Manish Shah1,
  6. Marlena J. Smith1,
  7. Darren Browning2,
  8. Jim Rawson3,
  9. Sylvia B. Smith1,
  10. John T. Barrett3 and
  11. Patricia V. Schoenlein1
  1. 1Departments of Cellular Biology and Anatomy, 2Biochemistry, and 3Radiology, Medical College of Georgia, Augusta, Georgia
  1. Requests for reprints: Patricia V. Schoenlein, Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, GA 30912. Phone: 706-721-3737; Fax: 706-721-6839. E-mail: pschoenl{at}mail.mcg.edu
View Full Text
PreviousNext
Back to top
Molecular Cancer Therapeutics: 7 (9)
September 2008
Volume 7, Issue 9
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance
Julia S. Samaddar, Virgil T. Gaddy, Jennifer Duplantier, Sudharsan Periyasamy Thandavan, Manish Shah, Marlena J. Smith, Darren Browning, Jim Rawson, Sylvia B. Smith, John T. Barrett and Patricia V. Schoenlein
Mol Cancer Ther September 1 2008 (7) (9) 2977-2987; DOI: 10.1158/1535-7163.MCT-08-0447

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance
Julia S. Samaddar, Virgil T. Gaddy, Jennifer Duplantier, Sudharsan Periyasamy Thandavan, Manish Shah, Marlena J. Smith, Darren Browning, Jim Rawson, Sylvia B. Smith, John T. Barrett and Patricia V. Schoenlein
Mol Cancer Ther September 1 2008 (7) (9) 2977-2987; DOI: 10.1158/1535-7163.MCT-08-0447
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Dihydrofolate reductase amplification and sensitization to methotrexate of methotrexate-resistant colon cancer cells
  • MAPK-independent impairment of T-cell responses by the multikinase inhibitor sorafenib
  • Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1)
Show more Research Articles: Therapeutics, Targets, and Development
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement